Today: 1 July 2026
Browse Category

Mergers and Acquisitions 2 February 2026 - 30 June 2026

Transocean (NYSE:RIG) moves against sector as Valaris spread stays close to 3%

Transocean (NYSE:RIG) moves against sector as Valaris spread stays close to 3%

Transocean Ltd. dropped 1.6% to $5.04 by late Monday. Trading was heavy, with 36.4 million shares traded, putting dollar volume around $184 million. That’s about 3.2% of the company’s market cap and ahead of the same day turnover rates for Noble Corp. Plc, Valaris Ltd., and Seadrill Ltd.. The way RIG trades is getting more attention now, since the stock is both an offshore driller bet and the currency for Transocean’s all-stock deal to buy Valaris. The agreement has Valaris holders set to get 15.235 Transocean shares for every Valaris share. With RIG at Monday’s close, that pegged Valaris at $76.78 a share. Valaris last traded at $74.53.
30 June 2026
··
Tesla Draws Attention as Traders Raise SpaceX Merger Bets on Record IPO

Tesla Draws Attention as Traders Raise SpaceX Merger Bets on Record IPO

Some traders are betting again that Elon Musk could put Tesla and SpaceX together, after SpaceX’s public listing gave the idea more traction. On Kalshi, a prediction market, the odds for a merger deal happening before March 1, 2027 are trading at 36%. That rises to 40% before April 1 and 54% before May 1. To settle, Kalshi says there must be a definitive, binding agreement announced in official company statements—rumors or early talks do not qualify. SpaceX President Gwynne Shotwell did not dismiss the idea of a tie-up with Tesla in a CNBC interview aired Friday. “That might make Elon’s life a little easier, actually,” Shotwell said. She pointed to synergies between the two companies but added her main focus now is on SpaceX operations and expansion, not a deal.
12 June 2026
··
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent is trading on deal odds now, not on drug data. Shares last traded at $123.25, up 39.28%, after GSK said it will buy the Nasdaq-listed biotech for $124 per share in cash. That leaves just a small discount to the offer price. Nuvalent’s stock is being valued more like a GSK takeover play than an oncology bet. Nuvalent stock got a new cap Tuesday after the company agreed to a buyout. GSK said it will make a tender offer for all outstanding Class A and Class B shares at $124 each, within 10 business days. Tender offers pay cash straight to shareholders and are often used to speed up takeovers. The $124 offer is 40% over Nuvalent’s previous close and 26% above its 30-day volume-weighted average price, which tracks average trading prices by volume.
10 June 2026
····
McCormick Shares Fall Again — Monday Seen as Key for Unilever Deal Impact

McCormick Shares Fall Again — Monday Seen as Key for Unilever Deal Impact

McCormick & Company shares finished down this week, settling at $46.35 on Friday, with traders still selling the stock after a volatile stretch over its planned Unilever Foods deal. No trading on the New York Stock Exchange Saturday, with the next regular core session scheduled for Monday. On Friday, stocks were hit as the S&P 500 dropped 1.2% and the Dow slipped 1.1%. Higher oil prices pushed yields up and hurt risk appetite.
16 May 2026
···
Terns Pharmaceuticals stock stops trading as Merck’s $53 cash deal takes over the chart

Terns Pharmaceuticals stock stops trading as Merck’s $53 cash deal takes over the chart

Terns Pharmaceuticals shares aren’t budging—not surprising, since the merger is done and Nasdaq trading is finished. The last quote for the stock came in at $52.95, just shy of Merck’s $53-per-share cash deal. With Terns now fully absorbed into Merck, its common stock has dropped off the Nasdaq Global Select Market and won’t trade again. This explains the chart’s flatline—no real movement left. When a cash buyout is nearly a done deal, the shares just shadow the expected payout, with barely any margin for risk or timing. In this case, almost no spread remained after Merck wrapped up its tender offer, leaving leftover shares automatically converted to $53 cash per share.
12 May 2026
····
Ondas Stock Jumps Before Earnings as New SEC Filing Puts M&A Shares in Focus

Ondas Stock Jumps Before Earnings as New SEC Filing Puts M&A Shares in Focus

Ondas Inc. climbed over 4% on Monday, with traders angling ahead of the defense-technology firm’s first-quarter earnings due this week and digesting new SEC filings linked to its brisk M&A streak. Shares last traded at $9.46, just below the session peak of $9.48. This shift is significant: Ondas isn’t just a minor player in wireless and drones with a backlog anymore. Over the last few months, the company’s been pushing to become a more comprehensive defense and autonomous systems platform. It’s been spending cash and issuing stock to snap up assets across drones, robotics, counter-drone tech, and high-altitude intelligence.
11 May 2026
···
Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

SAN MATEO, California, April 29, 2026, 11:05 PDT Upstart Holdings shares dropped Wednesday after the AI-driven lending platform announced affiliates of Fortress Investment Group will purchase up to $1.25 billion in consumer loans through its network over a 15-month period. The stock recently traded at $30.77, down $2.09. “Resilient and stable foundation,” is how Sanjay Datta, president of capital and enterprise at Upstart, described the agreement. Fortress Managing Director Matt Biczak pointed to “efficient access to scaled origination” as a key draw.
29 April 2026
··
Coca-Cola HBC Raises €2.1 Billion in Euro Bonds as Africa Deal Moves Ahead

Coca-Cola HBC Raises €2.1 Billion in Euro Bonds as Africa Deal Moves Ahead

Coca-Cola HBC landed a 2.1 billion euro bond deal Thursday, pulling in over 7.1 billion euros in orders—well above the 1.5 billion euros the company initially targeted. As the books swelled, pricing was cut back by no less than 0.30 percentage points from where talks began. Coca-Cola HBC plans to use the deal’s proceeds to cover general financing and refinancing, plus the cash portion tied to its planned buyout of Coca-Cola Beverages Africa, or CCBA. The move locks in a funding route for what’s set to be the company’s largest expansion in recent years, with the acquisition still on track to wrap up by the end of 2026.
27 March 2026
·
Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue has handed out new stock-based awards to top execs, filings show this week. Among them: a block of 122,286 restricted stock units for the general counsel. The consumer health outfit is still awaiting regulatory go-aheads for its planned sale to Kimberly-Clark. The filings take on extra weight as Kenvue navigates a lengthy, very public run-up to a change of control. During this stretch, investors and employees are watching retention, pay, and leadership stability with sharper focus than usual.
6 March 2026
···
Blackstone stock (BX): FERC clears $11.5B TXNM deal as private-credit nerves hang over Monday

Blackstone stock (BX): FERC clears $11.5B TXNM deal as private-credit nerves hang over Monday

New York, Feb 22, 2026, 14:12 EST — The session wrapped up with the market now closed. Blackstone picked up a key regulatory approval Friday: TXNM Energy announced that FERC signed off on its sale to Blackstone Infrastructure, while the Hart-Scott-Rodino antitrust period also ran out. Shares of Blackstone didn't catch a break, sliding $4.46, or 3.5%, to close at $121.27.
22 February 2026
···
BP Q4 2025 results: BP halts buybacks after $4bn write-downs and a $1.5bn U.S. asset deal

BP Q4 2025 results: BP halts buybacks after $4bn write-downs and a $1.5bn U.S. asset deal

BP hit the brakes on its share buyback program Tuesday, opting instead to channel extra cash toward trimming debt and boosting oil-and-gas spending, after quarterly underlying profit numbers landed largely in line with forecasts. The company also flagged roughly $4.2 billion in impairments and disclosed it had unloaded a minority stake in its U.S. onshore oil assets for $1.5 billion. The suspension of buybacks is a big deal—investors have counted on those returns as a cushion when prices weaken, and BP has turned to share repurchases to help calm nerves after years spent changing direction. BP stock is up around 9% year-to-date, ahead of European competitors Shell and TotalEnergies, but it’s still trailing ExxonMobil in the U.S., according to the Financial Times.
10 February 2026
··
Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

NEW YORK, February 4, 2026, 15:32 EST — Regular session Confluent, Inc. shares edged down 0.1% to $30.42 in Wednesday afternoon trading, fluctuating within a narrow band as the company awaits its upcoming sale to IBM. The stock traded between $30.28 and $30.50, still under the $31-per-share cash offer outlined in the merger deal.
4 February 2026
···
1 2 3 … 7

Stock Market Today

  • Danika Mason Says She's Expecting First Child With Liam Knight
    June 30, 2026, 9:57 PM EDT. Danika Mason, sport presenter on the Today show, said she is expecting her first child, a girl due in December. Mason and partner Liam Knight, former rugby league player, are looking forward to the new addition. Knight came back to Australia after playing in the UK so he could be with Mason. She has talked about her experience so far, from morning sickness to food cravings, drawing support from friends and colleagues. The couple confirmed their relationship in 2024 and got engaged while on a trip to Italy. The announcement drew congratulations from across the media and sports world.
Go toTop